$0.24 Earnings Per Share Expected for NextGen Healthcare, Inc. (NASDAQ:NXGN) This Quarter

Brokerages forecast that NextGen Healthcare, Inc. (NASDAQ:NXGN) will post $0.24 earnings per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for NextGen Healthcare’s earnings, with the lowest EPS estimate coming in at $0.21 and the highest estimate coming in at $0.28. NextGen Healthcare reported earnings of $0.30 per share during the same quarter last year, which would suggest a negative year over year growth rate of 20%. The business is expected to announce its next quarterly earnings results on Thursday, October 28th.

On average, analysts expect that NextGen Healthcare will report full-year earnings of $0.93 per share for the current fiscal year, with EPS estimates ranging from $0.91 to $0.94. For the next year, analysts expect that the business will report earnings of $0.99 per share, with EPS estimates ranging from $0.94 to $1.04. Zacks’ earnings per share calculations are an average based on a survey of sell-side analysts that cover NextGen Healthcare.

NextGen Healthcare (NASDAQ:NXGN) last released its earnings results on Thursday, July 29th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.11. NextGen Healthcare had a net margin of 2.31% and a return on equity of 12.73%. The business had revenue of $146.08 million during the quarter, compared to the consensus estimate of $139.97 million.

NXGN has been the subject of several recent research reports. Piper Sandler reissued an “overweight” rating and issued a $23.00 price objective (down previously from $24.00) on shares of NextGen Healthcare in a report on Thursday, May 27th. Royal Bank of Canada cut their target price on NextGen Healthcare from $21.00 to $19.00 and set a “sector perform” rating for the company in a research note on Friday, July 30th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating on shares of NextGen Healthcare in a research report on Thursday, June 24th. Finally, Colliers Securities restated a “buy” rating and issued a $21.00 target price on shares of NextGen Healthcare in a research report on Friday, July 30th. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus target price of $20.71.

In related news, Director Craig A. Barbarosh sold 9,000 shares of the stock in a transaction that occurred on Tuesday, August 3rd. The stock was sold at an average price of $16.14, for a total transaction of $145,260.00. Following the completion of the transaction, the director now directly owns 72,946 shares of the company’s stock, valued at $1,177,348.44. The sale was disclosed in a filing with the SEC, which is available through this link. 18.50% of the stock is currently owned by corporate insiders.

Large investors have recently bought and sold shares of the company. Caxton Associates LP bought a new stake in shares of NextGen Healthcare in the 1st quarter valued at approximately $214,000. Acadian Asset Management LLC lifted its stake in shares of NextGen Healthcare by 3.1% during the 1st quarter. Acadian Asset Management LLC now owns 774,719 shares of the company’s stock worth $14,024,000 after acquiring an additional 23,625 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in shares of NextGen Healthcare by 21.6% during the 1st quarter. JPMorgan Chase & Co. now owns 502,686 shares of the company’s stock worth $9,098,000 after acquiring an additional 89,388 shares during the last quarter. Martingale Asset Management L P lifted its stake in shares of NextGen Healthcare by 12.5% during the 1st quarter. Martingale Asset Management L P now owns 90,011 shares of the company’s stock worth $1,631,000 after acquiring an additional 10,013 shares during the last quarter. Finally, BNP Paribas Arbitrage SA lifted its stake in shares of NextGen Healthcare by 87.6% during the 1st quarter. BNP Paribas Arbitrage SA now owns 27,649 shares of the company’s stock worth $500,000 after acquiring an additional 12,912 shares during the last quarter. 74.11% of the stock is owned by institutional investors and hedge funds.

Shares of NASDAQ:NXGN opened at $14.76 on Friday. NextGen Healthcare has a 1-year low of $11.80 and a 1-year high of $23.80. The stock has a market cap of $992.85 million, a PE ratio of 73.80, a price-to-earnings-growth ratio of 2.73 and a beta of 1.15. The stock’s fifty day simple moving average is $15.71 and its two-hundred day simple moving average is $17.29.

About NextGen Healthcare

NextGen Healthcare, Inc engages in the development and marketing of electronic health records, practice management, revenue cycle management, and interoperability solutions. It offers the core; automation and workflow; analytics, population health, and patient engagement, interoperability; managed services; professional services; and client service and support.

Further Reading: What is the CBOE Russell 2000® Volatility Index?

Get a free copy of the Zacks research report on NextGen Healthcare (NXGN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for NextGen Healthcare (NASDAQ:NXGN)

Receive News & Ratings for NextGen Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextGen Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.